Eukroma Cream for Effective Hyperpigmentation Treatment
| Product dosage: 20g | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 1 | $47.19 | $47.19 (0%) | 🛒 Add to cart |
| 2 | $38.15 | $94.38 $76.31 (19%) | 🛒 Add to cart |
| 3 | $28.45 | $141.57 $85.34 (40%) | 🛒 Add to cart |
| 4 | $23.85 | $188.75 $95.38 (49%) | 🛒 Add to cart |
| 5 | $20.88 | $235.94 $104.42 (56%) | 🛒 Add to cart |
| 6 | $19.58 | $283.13 $117.47 (59%) | 🛒 Add to cart |
| 7 | $17.64 | $330.32 $123.49 (63%) | 🛒 Add to cart |
| 8 | $16.44 | $377.51 $131.53 (65%) | 🛒 Add to cart |
| 9 | $15.84 | $424.70 $142.57 (66%) | 🛒 Add to cart |
| 10 | $15.16
Best per tube | $471.89 $151.61 (68%) | 🛒 Add to cart |
Eukroma Cream is a topical dermatological formulation containing Hydroquinone as its active pharmaceutical ingredient. It is specifically indicated for the treatment of hyperpigmentation disorders, including melasma, chloasma, freckles, and post-inflammatory hyperpigmentation. This prescription-grade treatment works by inhibiting the enzymatic conversion of tyrosine to melanin, thereby reducing the overproduction of melanin in the skin. Clinical evidence supports its efficacy in achieving a more uniform skin tone when used under appropriate medical supervision as part of a comprehensive skincare regimen.
Features
- Contains 2% or 4% Hydroquinone USP as the active depigmenting agent
- Formulated in a hydrophilic base for optimal skin penetration
- Available in 15g and 30g aluminum tubes with tamper-evident packaging
- Manufactured under GMP-certified conditions ensuring pharmaceutical quality
- pH-balanced formulation to maintain skin barrier integrity
- Paraben-free and fragrance-free composition
Benefits
- Clinically proven reduction in the appearance of dark spots and uneven skin pigmentation
- Restoration of a more uniform and radiant skin tone through targeted melanin inhibition
- Prevention of further hyperpigmentation with consistent therapeutic use
- Improved skin texture and clarity through regular application
- Enhanced patient confidence through visible aesthetic improvements
- Compatible with comprehensive skincare routines when properly sequenced
Common use
Eukroma Cream is primarily prescribed for the management of hyperpigmentation conditions including melasma (mask of pregnancy), chloasma, solar lentigines (age spots), ephelides (freckles), and post-inflammatory hyperpigmentation resulting from acne, trauma, or cosmetic procedures. It may be used as monotherapy or in combination with other topical agents such as tretinoin and corticosteroids in modified Kligman’s formula for enhanced efficacy in resistant cases. Treatment duration typically ranges from 2-4 months with periodic evaluation by a dermatologist to assess response and adjust therapy as needed.
Dosage and direction
Apply a thin layer of Eukroma Cream to affected areas twice daily, typically in the morning and evening. Cleanse and dry the skin thoroughly before application. Use only enough cream to cover the hyperpigmented areas with a light film; excessive application does not enhance efficacy and may increase adverse effects. Gently massage into the skin until absorbed. Avoid application to surrounding normal skin to prevent unintended hypopigmentation. Treatment should not exceed 5 months continuously without medical supervision. Always wash hands thoroughly after application to prevent transfer to unintended areas.
Precautions
- For external use only; avoid contact with eyes, mucous membranes, and lips
- Discontinue use and consult your physician if irritation, redness, or itching develops
- Sun protection is mandatory during treatment; use broad-spectrum sunscreen with SPF 30 or higher
- Not recommended for use on broken, inflamed, or sunburned skin
- Periodic dermatological monitoring is advised to assess treatment response and skin condition
- May cause temporary skin sensitivity; avoid concomitant use of abrasive cleansers or exfoliants
- Treatment should be discontinued at least one month prior to elective cosmetic procedures
Contraindications
Eukroma Cream is contraindicated in patients with known hypersensitivity to hydroquinone or any component of the formulation. Should not be used by individuals with a history of allergic reaction to hydroquinone-containing products. Contraindicated in patients with phenylketonuria due to metabolic concerns. Not recommended for use during pregnancy or breastfeeding without thorough risk-benefit assessment. Avoid use in children under 12 years of age. Contraindicated in patients with pre-existing ochronosis or those who have previously developed ochronosis from hydroquinone use.
Possible side effects
Common side effects (≥1/100 to <1/10) include mild skin irritation, transient erythema, and dry skin. Uncommon side effects (≥1/1,000 to <1/100) may include burning sensation, stinging, or mild dermatitis. Rare side effects (<1/1,000) include allergic contact dermatitis, paradoxical hyperpigmentation, and ochronosis (blue-black discoloration) with prolonged use. Very rare cases of nail discoloration and localized exogenous ochronosis have been reported with extended use. Most side effects are mild and transient, typically resolving upon discontinuation of therapy.
Drug interaction
Concurrent use with other topical medications including benzoyl peroxide, hydrogen peroxide, or other oxidizing agents may cause temporary skin darkening. May enhance skin sensitivity when used with other potentially irritating topical products such as retinoids, alpha-hydroxy acids, or abrasive cleansers. Caution advised when using with topical corticosteroids due to potential enhanced systemic absorption. No significant pharmacokinetic interactions with systemic medications have been documented, though caution is advised with drugs known to cause photosensitivity.
Missed dose
If a dose is missed, apply the cream as soon as remembered unless it is nearly time for the next scheduled application. Do not double the dose to make up for a missed application. Maintain the regular twice-daily schedule without exceeding the recommended frequency. Consistent application is important for optimal results, but occasional missed doses are unlikely to significantly affect overall treatment efficacy.
Overdose
Excessive application may lead to increased incidence of adverse effects including severe irritation, burning sensation, and inflammation. Systemic absorption through intact skin is minimal with recommended use, but excessive application to large body surface areas could potentially lead to systemic effects including tinnitus, dizziness, nausea, and cyanosis (blue discoloration of skin due to methemoglobinemia). In case of suspected overdose, discontinue use immediately and seek medical attention. Treatment is supportive and symptomatic.
Storage
Store at room temperature (15-30°C) in the original container. Keep tube tightly closed when not in use to prevent oxidation and degradation of the active ingredient. Protect from light and excessive moisture. Do not freeze. Keep out of reach of children and pets. Discard any product that has changed color or consistency. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Eukroma Cream is a prescription medication and should be used only under the supervision of a qualified healthcare professional. Individual results may vary based on skin type, condition severity, and adherence to treatment protocol. Always follow your physician’s instructions regarding use, duration, and concomitant therapies. Not all possible uses, precautions, side effects, or interactions are listed here.
Reviews
Clinical studies demonstrate that 70-80% of patients show significant improvement in hyperpigmentation after 12 weeks of proper use. Dermatologists report satisfactory results in managing melasma when combined with sun protection measures. Some patients note initial mild irritation that typically subsides with continued use. Long-term users emphasize the importance of medical supervision to monitor treatment efficacy and skin response. Overall satisfaction rates are high among appropriately selected patients who follow prescribed usage guidelines.